This article about helminth and TSO therapy appeared recently in BusinessWeek (Now Bloomberg BusinessWeek) magazine. A longer version is accessible to users of the Bloomberg Professional Service.
A major double-blind, placebo controlled study of TSO therapy for allergic rhinitis is complete and about to be published in the Journal of Allergy and Clinical Immunology. Here is the citation: Bager P, Arnved J, Rønborg S, Wohlfahrt J, Poulsen LK, Westergaard T, Petersen HW, Kristensen
The Seaver Autism Center for Research and Treatment at Mount Sinai is interested in testing the hypothesis described in this site. Since my presentation in November 2007 there have been sufficient anecdotal reports of improvements in self-injurious and repetitive behaviors to warrant
My son (about to turn 18) was on TSO (2500 bi-weekly) for two years, and during that time there was a complete elimination of aggression, agitation, tantrums, melt-downs, OCD, etc. (see the rest of this site for the full history). For the last 8 months or so he has been increasingly quiet,
The video below is an excellent 5 minute overview of helminth therapy produced and created by Asphelia Pharmaceuticals.